U.S. Journalist and Media
Contact Information

The numbers listed below are for use by professional journalists and members of the media. If you are not a member of the media and need assistance, we ask that you please contact the company at
1-800-243-0127, Monday through Friday from 8:30 a.m. to 5:00 p.m., excluding holidays.

This contact information is not intended for reporting unexpected drug effects or adverse events for any Boehringer Ingelheim product. Please report any unexpected effects or product problems to the Drug Information Unit by calling 1-800-542-6257 (option 4).

U.S. Headquarters Contact Information

Boehringer Ingelheim Pharmaceuticals, Inc.
900 Ridgebury Road/P.O. Box 368
Ridgefield, CT 06877
1-800-243-0127

U.S. Corporate Media Inquiries

Amy Kunkel
203-798-5538
amy.kunkel@boehringer-ingelheim.com

Ann Wainright
203-791-6318
ann.wainright@boehringer-ingelheim.com

U.S. Products and Pipeline Media Inquiries - General

Kate O'Connor - Public Relations
203-791-6250
usnews@boehringer-ingelheim.com

U.S. Products by Therapeutic Area
Cardiovascular

Aggrenox^® (aspirin/ extended-release dipyridamole) capsules
Micardis^® (telmisartan) tablets

Anna Moses
203-798-4638
anna.moses@boehringer-ingelheim.com

Central Nervous System

Mirapex^® (pramipexole) tablets

Lara Crissey
203-798-4740
lara.crissey@boehringer-ingelheim.com

Diabetes

Kate O'Connor - Public Relations
203-791-6250
usnews@boehringer-ingelheim.com

HIV

Aptivus^® (tipranavir) capsules
Viramune^® (nevirapine) tablets

Susan Holz
203-798-4265
susan.holz@boehringer-ingelheim.com

Oncology

Jennifer Soares
203-791-6784
jennifer.soares@boehringer-ingelheim.com

Respiratory

Atrovent^® HFA (ipratropium bromide HFA) Inhalation Aerosol
Combivent^® (ipratropium bromide and albuterol sulfate)
Spiriva^® HandiHaler^® (tiotropium bromide inhalation powder)

Emily Baier
203-791-5997
emily.baier@boehringer-ingelheim.com

Women's Health/HSDD